Endothelial function of asthma patients in stable state and during exacerbation Source: Eur Respir J 2003; 22: Suppl. 45, 279s Year: 2003
Relationships between stable state inflammation and time to exacerbation in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 177s Year: 2006
Vip in the serum of asthmatic patients and in COPD patients in stable state and during exacerbation Source: Eur Respir J 2007; 30: Suppl. 51, 403s Year: 2007
Determinants of endothelial function in patients with COPD Source: Eur Respir J 2013; 42: 1194-1204 Year: 2013
New markers of endothelial dysfunction in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 143s Year: 2007
New markers of endothelial dysfunction in patients with COPD Source: Annual Congress 2009 - Pulmonary hypertension Year: 2009
Evaluation of endothelial dysfunction at the patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 316s Year: 2004
Association between endothelial function and pulmonary function in patients with chronic obstructive pulmonary disease Source: International Congress 2017 – Highlights on clinical problems in COPD Year: 2017
Catabolic/anabolic balance in patients with COPD exacerbation Source: Eur Respir J 2004; 24: Suppl. 48, 305s Year: 2004
Differences in vessel endothelium function in severe COPD and severe asthma patients Source: Eur Respir J 2006; 28: Suppl. 50, 404s Year: 2006
Alterations in sputum inflammatory markers during exacerbations for COPD patients with different stable state levels Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019
Hypoxaemia and endothelial dysfunctional in patients with COPD Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease Year: 2009
Increased circulating fibrocytes and their capacity of proliferation and differentiation in clinically unstable patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013
1 year evolution of COPD patients systemic endothelial dysfunction Source: Eur Respir J 2005; 26: Suppl. 49, 718s Year: 2005
Predictive factors of endothelial function in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Prognosis in COPD Year: 2008
Correction of endothelial dysfunction in patients with COPD, IPF Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010
The state of patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2007; 30: Suppl. 51, 547s Year: 2007
Midrange-proadrenomedullin in stable state predicts severe exacerbation of COPD Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016
Determinants of exacerbation rate in patients with stable COPD Source: Eur Respir J 2004; 24: Suppl. 48, 661s Year: 2004
Cilomilast decreases exacerbations and maintains lung function in patients with poorly reversible COPD Source: Eur Respir J 2004; 24: Suppl. 48, 88s Year: 2004